PMA device
Interstim System
Medtronic Neuromodulation · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Nov 17, 2003, newest Aug 25, 2011Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
43
Naming "Interstim"
MAUDE reports
56,748
Brand "Interstim", since 2015
PubMed studies
226
Mentioning "Interstim"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Interstim System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- INTERSTIM SYSTEMPMA supplement
P970004-S121 · Decided Aug 25, 2011 · 44 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
- INTERSTIM FAMILY OF NEUROSTIMULATION LEADSPMA supplement
P970004-S075 · Decided Oct 15, 2009 · 52 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
P970004-S026 · Decided Nov 17, 2003 · 87 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Interstim", any status and sponsor, newest update first.
Odense University HospitalAcademic, hospital or other
NCT05380856 · 60 participants (planned) · Start Aug 18, 2023 · Primary completion Sep 1, 2027
Device: Turning ON the neuromodulator; Turning OFF the neuromodulator · For: Neurogenic Dysfunction of the Urinary Bladder; Multiple Sclerosis; Sacral Neuromodulation and 3 more
Sites: Odense, Denmark
- Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract DysfunctionNot yet recruiting
Fundación Santa Fe de BogotaAcademic, hospital or other
NCT07856238 · 1,700 participants (planned) · Start Dec 1, 2026 · Primary completion May 1, 2027
Device: InterStim™ Sacral Neuromodulation System II - X · For: Overactive Bladder (OAB); Urgency Urinary Incontinence; Non-obstructive Urinary Retention and 1 more
Sites: Bogotá, Colombia
Corewell Health EastAcademic, hospital or other
NCT06150599 · 25 participants (planned) · Start Jan 27, 2026 · Primary completion Apr 1, 2028
Device: Sacral neuromodulation · For: Chronic Pelvic Pain Syndrome
Sites: Royal Oak, Michigan
40 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Interstim", and for the whole product code for context.
This brand
56,748 reports: 29,940 malfunction, 26,786 injury, 20 death
Whole product code EZW
68,097 reports: 34,391 malfunction, 33,649 injury, 34 death
Newest reports for this brand
- InterStim XInjury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18518 · Received Oct 30, 2026 · Event dated Mar 1, 2026
Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Device problem as coded: Migration or Expulsion of Device; Inappropriate/Inadequate Shock/Stimulation; Positioning Problem; Patient Device Interaction Problem
Patient problem as coded: Pain; Electric Shock; Insufficient Information
- INTERSTIM¿Injury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18521 · Received Oct 30, 2026
Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Device problem as coded: Malposition of Device; Insufficient Device Problem Information
Patient problem as coded: Pain; Insufficient Information
- InterStim XInjury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18534 · Received Oct 30, 2026 · Event dated Oct 19, 2026
Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Erythema; Hypersensitivity/Allergic reaction; Unspecified Infection; Inflammation; Rash
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0372-2025 · Started Sep 18, 2024 · Posted by FDA Nov 13, 2024
Reason given: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-0998-2022 · Started Feb 28, 2022 · Posted by FDA Apr 22, 2022
Reason given: There is a software anomaly with the InterStim X Clinician software application with results in the data entered in the Patient Information fields not e retained and a " Data Lost" notification being displayed.
Cause as FDA categorized it: Software Design Change · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Z-1147-2015 · Started Jan 9, 2015 · Posted by FDA Jun 26, 2015
Reason given: Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate displayed on the Model 8840Programmer may be inaccurate.
Cause as FDA categorized it: Other · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Interstim"[tiab]. The summary above synthesizes these.
- Neuromodulation.
Noblett K, Crowder C · Obstet Gynecol Clin North Am · 2021Review
- InterStim.
Gardner D · Urol Nurs · 2011Letter, Comment
- Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems.
Meng L, Tian Z, Zhang Y, et al. · Sci Rep · 2022Research Support, Non-U.S. Gov't
- Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study.
Chartier-Kastler E, Normand LL, Ruffion A, et al. · Eur Urol Focus · 2022Observational Study, Multicenter Study
- Outcomes associated with Interstim therapy for medically refractory fecal incontinence.
McNevin MS, Moore M, Bax T · Am J Surg · 2014Evaluation Study
- Troubleshooting Interstim Sacral Neuromodulation Generators to Recover Function.
Powell CR · Curr Urol Rep · 2018Review
- Sacral nerve stimulation: Interstim therapy.
Peeren F, Hoebeke P, Everaert K · Expert Rev Med Devices · 2005Review
- Sacral Neuromodulation: Standardized Electrode Placement Technique.
Matzel KE, Chartier-Kastler E, Knowles CH, et al. · Neuromodulation · 2017
- Sacral neuromodulation with the InterStimࡊ system for faecal incontinence: results from a prospective French multicentre observational study.
Meurette G, Siproudhis L, Leroi AM, et al. · Colorectal Dis · 2021Multicenter Study, Observational Study
- Sacral Neuromodulation with the InterStimࡊ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
Chartier-Kastler E, Le Normand L, Ruffion A, et al. · Eur Urol Focus · 2021Multicenter Study, Observational Study
- Retrospective study of sacral neuromodulator implantations in a French hospital center: Lifespan and hospital costs assessment.
Daikh A, Reymond F, Lombardo D, et al. · Int J Colorectal Dis · 2023
- InterStim Therapy: A Contemporary Approach to Overactive Bladder.
Kohli N, Patterson D · Rev Obstet Gynecol · 2009
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Neuspera Sacral Neuromodulation (SNM) SystemNeuspera Medical, Inc. · PMA 2026
- Master InterStim® Therapy System, Verify® Evaluation SystemMedtronic Neuromodulation · PMA 2022
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
- Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel ControlMedtronic Neuromodulation · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.